Ra Medical Systems (RMED) IPO Stock Settlement

Ra Medical Systems (RMED) IPO Stock Settlement — Claim by July 2022

Updated: December 10, 2022

Claim Form Deadline: July 9, 2022

Estimated Payout: Varies

Proof required: Yes

What's This Settlement About?

A class action settlement has been reached in order to settle a lawsuit against RA Medical Systems Inc and their publically traded stock, RMED listed on NASDAQ. The lawsuit stems from allegations that RA Medical made material misstatements and/or omitted material facts about RA Medical's operations, including product defects with DABRA catheters, product recall, off-label marketing of DABRA, and improper payments to physicians. Pursuant to the Settlement, Defendants have agreed to pay or cause to be paid $10,000,000 in cash.

How Do I Qualify?

The Settlement Class consists of all persons and entities that purchased or otherwise acquired the common stock of RA Medical:

• pursuant and/or traceable to RA Medical's IPO; and/or
• between September 27, 2018 and November 27, 2019, inclusive.

How Do I File a Claim?

To be eligible for a payment from the proceeds of the Settlement, you must have submitted a claim form online or postmarked no later than July 9, 2022.

The Court held a hearing on June 13, 2022 at 11:30 a.m.